Xin Liu

机构：Harbin University of Science and Technology, Guiyang College of Traditional Chinese Medicine, Heilongjiang University of Science and Technology, Guizhou University, Chengdu Medical College, Beijing Zhenxing Metrology & Measurement Institute, Aeronautical Development Establishment, Beijing Institute of Power Machinery (China), Chengdu University, First Affiliated Hospital of Chengdu Medical College, Affiliated Hospital of Jining Medical University, Shandong First Medical University, Xi’an Jiaotong-Liverpool University · ORCID：0000-0002-6542-3181

发表论文 73 篇 · 总被引 2412 次 · h-index 20

代表论文

Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy (2024 · Cell Reports · 被引 22)
Dietary iron intake and its impact on osteopenia/osteoporosis (2023 · BMC Endocrine Disorders · 被引 21)
Therapeutic target database 2026: facilitating targeted therapies and precision medicine (2025 · Nucleic Acids Research · 被引 20)
Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma (2025 · Current Molecular Pharmacology · 被引 10)
Understanding the nutritional benefits through plant proteins-probiotics interactions: mechanisms, challenges, and perspectives (2024 · Critical Reviews in Food Science and Nutrition · 被引 10)
Bacterial effector restricts liquid-liquid phase separation of ZPR1 to antagonize host UPRER (2023 · Cell Reports · 被引 9)